Omega Diagnostics logo

ODX - Omega Diagnostics Share Price

71.5p -0.5  -0.7%

Last Trade - 14/05/21

Small Cap
Market Cap £130.6m
Enterprise Value £125.5m
Revenue £8.52m
Position in Universe 973rd / 1826
Unlock ODX Revenue
Relative Strength (%)
1m -10.1%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -43.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
12.1 12.7 14.2 8.33 8.76 9.82 9.30 14.7 -4.1%
+2.6 -22.5 +24.0
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 September 2020, OmegaDiagnostics Group Plc revenues decreased 29% to £3.2M. Netloss before extraordinary items decreased 12% to £284K.Revenues reflect Health and Nutrition segment decrease of37% to £2.6M, Europe segment decrease of 51% to £730K,North America segment decrease of 97% to £22K,Africa/Middle East segment decrease of 58% to £223K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for ODX
Graphical History


ODX Revenue Unlock ODX Revenue

Net Income

ODX Net Income Unlock ODX Revenue

Normalised EPS

ODX Normalised EPS Unlock ODX Revenue

PE Ratio Range

ODX PE Ratio Range Unlock ODX Revenue

Dividend Yield Range

ODX Dividend Yield Range Unlock ODX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
ODX EPS Forecasts Unlock ODX Revenue
Profile Summary

Omega Diagnostics Group PLC is a medical diagnostics company. The Company's segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers. For allergy, it offers Allergodip, which is an enzyme immunoassay for the semi-quantitative determination of Specific immunoglobulin E (IgE) in serum or plasma. For anemia, it offers ATHOZYME Ferritin, which is an enzyme-immunoassay (ELISA) test for the detection and quantification of Ferritin in human serum. It offers a range of products for Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Antiphospholipid Syndrome (APS), Connective Tissue Disease, Gastrointestinal, and Vasculitis and Renal Disease. Its Fertility Hormones products include PATHOZYME-LH (Luteinizing Hormone), PATHOZYME-Prolactin and PATHOZYME-Oestradiol.

Last Annual March 31st, 2020
Last Interim September 30th, 2020
Incorporated January 16, 2004
Public Since March 18, 2004
No. of Shareholders: n/a
No. of Employees: 152
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 305,878,019
Free Float (0.0%)
Eligible for
ODX Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ODX
Upcoming Events for ODX
Monday 12th July, 2021 Estimate
Full Year 2021 Omega Diagnostics Group PLC Earnings Release
Thursday 26th August, 2021 Estimate
Omega Diagnostics Group PLC Annual Shareholders Meeting
Frequently Asked Questions for Omega Diagnostics
What is the Omega Diagnostics share price?

As of 14/05/21, shares in Omega Diagnostics are trading at 71.5p, giving the company a market capitalisation of £130.6m. This share price information is delayed by 15 minutes.

How has the Omega Diagnostics share price performed this year?

Shares in Omega Diagnostics are currently trading at 71.5p and the price has moved by 46.25% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Omega Diagnostics price has moved by 17.58% over the past year.

What are the analyst and broker recommendations for Omega Diagnostics?

Of the analysts with advisory recommendations for Omega Diagnostics, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Omega Diagnostics is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Omega Diagnostics next release its financial results?

Omega Diagnostics is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Omega Diagnostics dividend yield?

Omega Diagnostics does not currently pay a dividend.

Does Omega Diagnostics pay a dividend?

Omega Diagnostics does not currently pay a dividend.

When does Omega Diagnostics next pay dividends?

Omega Diagnostics does not currently pay a dividend.

How do I buy Omega Diagnostics shares?

To buy shares in Omega Diagnostics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Omega Diagnostics?

Shares in Omega Diagnostics are currently trading at 71.5p, giving the company a market capitalisation of £130.6m.

Where are Omega Diagnostics shares listed? Where are Omega Diagnostics shares listed?

Here are the trading details for Omega Diagnostics:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: ODX
What kind of share is Omega Diagnostics?

Based on an overall assessment of its quality, value and momentum, Omega Diagnostics is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Omega Diagnostics share price forecast 2021?

Shares in Omega Diagnostics are currently priced at 71.5p. At that level they are trading at 65.03% premium to the analyst consensus target price of 43.33.

Analysts covering Omega Diagnostics currently have a consensus Earnings Per Share (EPS) forecast of -0.0002 for the next financial year.

How can I tell whether the Omega Diagnostics share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Omega Diagnostics. Over the past six months, the relative strength of its shares against the market has been 16.52%. At the current price of 71.5p, shares in Omega Diagnostics are trading at -1.59% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Omega Diagnostics PE Ratio?

The Omega Diagnostics PE ratio based on its reported earnings over the past 12 months is 45.17. The shares are currently trading at 71.5p.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Omega Diagnostics?

Omega Diagnostics's management team is headed by:

Kieron Harbinson - FID
Jag Grewal - EDR
Edward Valente - OTH
Mike Gordon - OTH
Iain Logan - CTR
Prashant Maniar - OTH
Jamie Yexley - OTH
Karsten Brenzke - OTH
William Rhodes - NED
Colin King - CEO
Jeremy Millard - NID
Simon Douglas - NEC
Who are the major shareholders of Omega Diagnostics?

Here are the top five shareholders of Omega Diagnostics based on the size of their shareholding:

Evans (David Eric) Individual Investor
Percentage owned: 2.87% (5.25m shares)
Unicorn Asset Management Ltd. Investment Advisor
Percentage owned: 2.34% (4.27m shares)
Harwood Capital LLP Investment Advisor
Percentage owned: 1.92% (3.50m shares)
MI Sterling Select Companies Fund Mutual Fund
Percentage owned: 1.55% (2.83m shares)
Thornbridge Investment Management LLP Investment Advisor
Percentage owned: 1.55% (2.83m shares)
Similar to ODX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.